TABLE 1.
Consensus B reference amino acid | Position | Amino acid change | Mutation prevalence (%) |
Presence of mutation on expert list fromb: |
|||||
---|---|---|---|---|---|---|---|---|---|
PI naïve (n = 17,581) | PI treated (%) (n = 9,307) | H | A | R | I | L | |||
L | 10 | F | 0.24 | 12 | √ | √ | √ | √ | √ |
R | 0.02 | 0.65 | √ | √ | √ | √ | |||
Y | 0 | 0.42 | √ | √ | |||||
V | 11 | L | 0.05 | 1.1 | √ | ||||
I | 13 | M | 0.01 | 0.69 | |||||
K | 20 | T | 0.06 | 5.4 | √ | √ | √ | √ | √ |
A | 22 | V | 0.11 | 1.3 | √ | ||||
L | 23 | I | 0.05 | 1.8 | √ | √ | √ | ||
L | 24 | I | 0.01 | 8.1 | √ | √ | √ | √ | √ |
F | 0.08 | 0.92 | √ | √ | |||||
M | 0 | 0.24 | |||||||
D | 30 | N | 0.01 | 8.8 | √ | √ | √ | √ | √ |
V | 32 | I | 0.01 | 7.5 | √ | √ | √ | √ | √ |
L | 33 | M | 0 | 0.26 | √ | ||||
E | 34 | Q | 0.09 | 4.4 | √ | √ | |||
D | 0.05 | 0.49 | |||||||
N | 0 | 0.14 | |||||||
L | 38 | W | 0.01 | 0.36 | √ | ||||
K | 43 | T | 0.12 | 7.6 | √ | √ | √ | √ | |
I | 0.02 | 0.33 | |||||||
K | 45 | I | 0.01 | 0.18 | √ | √ | |||
V | 0 | 0.15 | |||||||
M | 46 | I | 0.30 | 30 | √ | √ | √ | √ | √ |
L | 0.27 | 13 | √ | √ | √ | √ | √ | ||
V | 0.06 | 0.68 | √ | ||||||
I | 47 | V | 0.05 | 7.2 | √ | √ | √ | √ | √ |
A | 0 | 0.45 | √ | √ | √ | √ | √ | ||
G | 48 | V | 0 | 6.3 | √ | √ | √ | √ | √ |
M | 0 | 0.82 | √ | √ | √ | ||||
A | 0 | 0.52 | √ | √ | |||||
L | 0 | 0.16 | |||||||
Q | 0 | 0.13 | |||||||
I | 50 | V | 0.02 | 2.8 | √ | √ | √ | √ | √ |
L | 0.01 | 0.64 | √ | √ | √ | √ | √ | ||
G | 51 | A | 0.01 | 0.38 | |||||
F | 53 | L | 0.04 | 8.4 | √ | √ | √ | √ | √ |
Y | 0.03 | 0.74 | √ | √ | √ | √ | |||
I | 54 | V | 0 | 31 | √ | √ | √ | √ | √ |
L | 0.01 | 4.7 | √ | √ | √ | √ | √ | ||
M | 0 | 3.9 | √ | √ | √ | √ | √ | ||
A | 0 | 1.8 | √ | √ | √ | √ | √ | ||
T | 0.02 | 1.5 | √ | √ | √ | √ | √ | ||
S | 0 | 1.2 | √ | √ | √ | √ | √ | ||
K | 55 | R | 0.25 | 9.6 | √ | ||||
N | 0.03 | 0.3 | |||||||
Q | 58 | E | 0.24 | 8.8 | √ | √ | √ | √ | √ |
I | 66 | F | 0.03 | 2.3 | √ | ||||
V | 0.08 | 1.8 | |||||||
L | 0.01 | 0.64 | |||||||
C | 67 | F | 0.03 | 1.8 | |||||
L | 0.01 | 0.24 | |||||||
A | 71 | I | 0.07 | 4.6 | √ | √ | √ | √ | √ |
L | 0 | 0.64 | √ | √ | √ | √ | |||
G | 73 | S | 0.03 | 13 | √ | √ | √ | √ | √ |
T | 0 | 4.1 | √ | √ | √ | √ | |||
C | 0.01 | 2.0 | √ | √ | √ | √ | |||
A | 0 | 1.1 | √ | √ | √ | √ | |||
V | 0.01 | 0.24 | √ | ||||||
T | 74 | P | 0.06 | 2.6 | √ | √ | √ | √ | |
K | 0.04 | 0.4 | |||||||
E | 0 | 0.19 | √ | ||||||
L | 76 | V | 0.01 | 4.4 | √ | √ | √ | √ | √ |
P | 79 | A | 0.12 | 1.4 | |||||
V | 82 | A | 0.03 | 29 | √ | √ | √ | √ | √ |
T | 0.01 | 4.3 | √ | √ | √ | √ | √ | ||
F | 0 | 2.4 | √ | √ | √ | √ | √ | ||
S | 0.01 | 1.8 | √ | √ | √ | √ | √ | ||
C | 0 | 0.93 | √ | √ | √ | ||||
L | 0.02 | 0.35 | √ | √ | √ | √ | |||
M | 0 | 0.28 | √ | √ | √ | √ | |||
N | 83 | D | 0.02 | 1.0 | √ | √ | √ | ||
S | 0.02 | 0.32 | |||||||
I | 84 | V | 0.01 | 21 | √ | √ | √ | √ | √ |
A | 0 | 0.27 | √ | √ | √ | √ | |||
C | 0 | 0.24 | √ | √ | |||||
I | 85 | V | 0.12 | 6.9 | √ | √ | √ | √ | |
N | 88 | D | 0.05 | 6.8 | √ | √ | √ | √ | √ |
S | 0.05 | 2.1 | √ | √ | √ | √ | √ | ||
T | 0.01 | 0.20 | √ | ||||||
G | 0 | 0.19 | √ | √ | |||||
L | 89 | V | 0.10 | 5.9 | √ | √ | √ | √ | |
T | 0.01 | 0.36 | √ | √ | √ | ||||
L | 90 | M | 0.23 | 43 | √ | √ | √ | √ | √ |
T | 91 | S | 0.01 | 2.5 | √ | ||||
Q | 92 | R | 0.13 | 1.3 | |||||
C | 95 | F | 0.02 | 2.6 | √ | √ | |||
L | 0.01 | 0.20 | |||||||
V | 0.01 | 0.20 |
Nonpolymorphic PI-selected mutations identified in the current analysis that were not identified in our 2005 analysis (26) are shown in boldface type.
A, ANRS; H, HIVDB; I, IAS-USA; L, Los Alamos National Laboratory; R, Rega. A checkmark indicates that the mutation is present on the expert list indicated.